Market Overview:
The global desmopressin market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of diabetes, rising geriatric population, and growing demand for desmopressin products in emerging markets. Based on type, the global desmopressin market is segmented into oral, intravenous injection, and nasal spray products. The oral product segment is expected to account for the largest share of the global desmopressin market in 2018. This segment is also projected to grow at a higher CAGR than other segments during the forecast period owing to its high adoption rate across regions. By application, hospital pharmacies accounted for the majority share of the global desmopressin market in 2017 and are expected to maintain their dominance duringthe forecast period as well.
Product Definition:
A synthetic hormone used to treat central diabetes insipidus, a condition characterized by excessive thirst and the production of large amounts of urine. Desmopressin is also used to control bed-wetting in children.
Oral:
Oral is a drug that is administered by mouth. It may be used to treat certain types of diabetes and kidney disease. It works by reducing the amount of fluid present in the body, thereby lowering the blood pressure and heart rate.
Intravenous Injection:
Intravenous injection is a drug delivery system that allows the administration of drugs by means of a needle. Intravenous injections are used to treat conditions such as insufficiently responsive diabetes, hypertension, and others. The most commonly used intravenous injection is desmopressin (DMD) for treatment of nocturnal enuresis in children and adults with bedbound illnesses or those who cannot urinate at night due to physical restraints or other medical conditions.
Application Insights:
Based on application, the global desmopressin market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and others. The online pharmacy segment is anticipated to witness significant growth over the forecast period owing to various benefits offered such as convenience and flexibility. Moreover, an increase in healthcare spending has led to a rise in demand for generic drugs which also plays a major role in driving the market.
The hospital pharmacy application was estimated to be the largest segment with a share of over 60% of overall revenue in 2017 due largely to increasing usage rates across hospitals globally. In addition, an increase in healthcare spending has led retailers from countries such as Germany and Australia who are specialized retail pharmacists have started their own chain of stores that offer medical consultation services along with prescriptions for medicines required by patients (i). Such factors are likely drive demand for desmopressin globally over the forecast period.
Regional Analysis:
North America dominated the global desmopressin market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing awareness about various products, such as nasal spray and oral tablets, developed healthcare infrastructure, and high disposable income of consumers in this region.
Asia Pacific is anticipated to witness a lucrative growth rate over the forecast period owing to rising demand for generic drugs due to low prices of branded drugs in this region. Moreover, growing medical tourism industry will also drive growth of market for desmopressin analogs over the next eight years. In addition, increasing number of retail pharmacies selling OTC medicines will further boost regional demand during the forecast period from 2018 till 2030 (estimated). However, high cost associated with clinical trials may pose a challenge for regional growth at some point during future years (2030).
Growth Factors:
- Increasing incidence of diabetes: The number of people affected by diabetes is increasing at an alarming rate all over the world. This is expected to drive the demand for desmopressin in the coming years as it is used for treating diabetes-related complications such as hyperglycemia and polyuria.
- Growing awareness about desmopressin: There is a growing awareness among people about the benefits of using desmopressin for various medical conditions. This is likely to boost demand for the drug in the coming years.
- Rising use of desmopressin in pediatric patients: Desmopressin has been found to be effective in pediatric patients for treating bedwetting and other urinary problems. This is likely to fuel its demand in the near future.
Scope Of The Report
Report Attributes
Report Details
Report Title
Desmopressin Market Research Report
By Type
Oral, Intravenous Injection, Nasal Spray
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Ferring Pharmaceuticals, Cadila Healthcare, Shanghai Soho-Yiming Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Desmopressin Market Report Segments:
The global Desmopressin market is segmented on the basis of:
Types
Oral, Intravenous Injection, Nasal Spray
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ferring Pharmaceuticals
- Cadila Healthcare
- Shanghai Soho-Yiming Pharmaceuticals
Highlights of The Desmopressin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Intravenous Injection
- Nasal Spray
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Desmopressin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Desmopressin is a hormone that regulates the body's water balance. It is used to treat conditions such as diabetes, high blood pressure, and renal (kidney) failure.
Some of the major companies in the desmopressin market are Ferring Pharmaceuticals, Cadila Healthcare, Shanghai Soho-Yiming Pharmaceuticals.
The desmopressin market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Desmopressin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Desmopressin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Desmopressin Market - Supply Chain
4.5. Global Desmopressin Market Forecast
4.5.1. Desmopressin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Desmopressin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Desmopressin Market Absolute $ Opportunity
5. Global Desmopressin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Desmopressin Market Size and Volume Forecast by Type
5.3.1. Oral
5.3.2. Intravenous Injection
5.3.3. Nasal Spray
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Desmopressin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Desmopressin Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Desmopressin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Desmopressin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Desmopressin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Desmopressin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Desmopressin Demand Share Forecast, 2019-2026
9. North America Desmopressin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Desmopressin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Desmopressin Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Desmopressin Market Size and Volume Forecast by Type
9.7.1. Oral
9.7.2. Intravenous Injection
9.7.3. Nasal Spray
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Desmopressin Demand Share Forecast, 2019-2026
10. Latin America Desmopressin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Desmopressin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Desmopressin Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Desmopressin Market Size and Volume Forecast by Type
10.7.1. Oral
10.7.2. Intravenous Injection
10.7.3. Nasal Spray
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Desmopressin Demand Share Forecast, 2019-2026
11. Europe Desmopressin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Desmopressin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Desmopressin Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Desmopressin Market Size and Volume Forecast by Type
11.7.1. Oral
11.7.2. Intravenous Injection
11.7.3. Nasal Spray
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Desmopressin Demand Share, 2019-2026
12. Asia Pacific Desmopressin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Desmopressin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Desmopressin Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Desmopressin Market Size and Volume Forecast by Type
12.7.1. Oral
12.7.2. Intravenous Injection
12.7.3. Nasal Spray
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Desmopressin Demand Share, 2019-2026
13. Middle East & Africa Desmopressin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Desmopressin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Desmopressin Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Desmopressin Market Size and Volume Forecast by Type
13.7.1. Oral
13.7.2. Intravenous Injection
13.7.3. Nasal Spray
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Desmopressin Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Desmopressin Market: Market Share Analysis
14.2. Desmopressin Distributors and Customers
14.3. Desmopressin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Ferring Pharmaceuticals
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Cadila Healthcare
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Shanghai Soho-Yiming Pharmaceuticals
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. COMPANY4
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
